Insider · CIK 0001319460

Joseph Donald

Reports to the SEC for 3 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001319460

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-11-17	Acer Therapeutics Inc.D Disposition to Issuer	See Remarks	DDisposition to Issuer	−14.3K sh	—	—	0
2023-03-14	Acer Therapeutics Inc.Employee Stock Option (right to buy)A Award	See Remarks	AAward	+30K sh	—	—	30,000
2022-05-31	ACHVACHIEVE LIFE SCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+4,400 sh	—	—	4,400
2022-01-14	Acer Therapeutics Inc.Employee Stock Option (right to buy)A Award	See Remarks	AAward	+25K sh	—	—	25,000
2021-05-11	ACHVACHIEVE LIFE SCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+3,750 sh	—	—	3,750
2021-01-15	Acer Therapeutics Inc.Employee Stock Option (right to buy)A Award	See Remarks	AAward	+60K sh	—	—	60,000
2020-07-24	Acer Therapeutics Inc.P Purchase	See Remarks	PPurchase	+14.3K sh	$3.50	+$50K	14,285
2020-05-12	ACHVACHIEVE LIFE SCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+22K sh	—	—	22,000
2019-09-18	Acer Therapeutics Inc.Employee Stock Option (right to buy)A Award	See Remarks	AAward	+40K sh	—	—	40,000
2019-05-14	ACHVACHIEVE LIFE SCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2019-02-01	Acer Therapeutics Inc.Employee Stock Option (right to buy)A Award	See Remarks	AAward	+27K sh	—	—	27,000
2018-09-20	ACHVACHIEVE LIFE SCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2018-04-20	Acer Therapeutics Inc.Employee Stock Option (right to buy)A Award	See Remarks	AAward	+60K sh	—	—	60,000
2017-08-01	ACHVACHIEVE LIFE SCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+16.4K sh	—	—	16,400
2017-08-01	ACHVACHIEVE LIFE SCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+16.4K sh	—	—	16,400
2015-02-16	HUMANIGEN, INCStock Options (right to buy)A Award	Chief Legal Officer	AAward	+300K sh	—	—	300,000
2014-01-19	HUMANIGEN, INCStock Option (right to buy)A Award	Chief Legal Officer	AAward	+40K sh	—	—	40,000
2013-07-30	HUMANIGEN, INCStock Option (right to buy)A Award	Chief Legal Officer	AAward	+125K sh	—	—	125,000

Recent filings

Accepted (ET)
Nov 204
Joseph Donald0000899243-23-020441
SEC(opens sec.gov)
Mar 164
Joseph Donald0001209191-23-019327
SEC(opens sec.gov)
Jun 14
Joseph Donald0001209191-22-033137
SEC(opens sec.gov)
Jan 194
Joseph Donald0001209191-22-003720
SEC(opens sec.gov)
May 134
Joseph Donald0001209191-21-032331
SEC(opens sec.gov)
Jan 204
Joseph Donald0001209191-21-004279
SEC(opens sec.gov)
Jul 284
Joseph Donald0001209191-20-043803
SEC(opens sec.gov)
May 144
Joseph Donald0001209191-20-029145
SEC(opens sec.gov)
Sep 234
Joseph Donald0001209191-19-050506
SEC(opens sec.gov)
May 154
Joseph Donald0001209191-19-030043
SEC(opens sec.gov)
Feb 54
Joseph Donald0001209191-19-007243
SEC(opens sec.gov)
Sep 214
Joseph Donald0001209191-18-051904
SEC(opens sec.gov)
Apr 234
Joseph Donald0001209191-18-025840
SEC(opens sec.gov)
Sep 124/A
Joseph Donald0001209191-17-052393
SEC(opens sec.gov)
Aug 34
Joseph Donald0001209191-17-047584
SEC(opens sec.gov)
Feb 184
KALOBIOS PHARMACEUTICALS INC0001209191-15-015574
SEC(opens sec.gov)
Jan 224
KALOBIOS PHARMACEUTICALS INC0001181431-14-003368
SEC(opens sec.gov)
Aug 14
KALOBIOS PHARMACEUTICALS INC0001181431-13-042286
SEC(opens sec.gov)

Companies

Address

C/O KALOBIOS PHARMACEUTICALS, INC. 260 EAST GRAND AVENUE

SOUTH SAN FRANCISCO, CA, 94080